Summary of Classification and Labelling
Notified classification and labelling
General Information
829-305-4 |
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide - (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride (1:1:1) |
1221565-82-7 |
Notified classification and labelling according to CLP criteria
Acute Tox. 3 |
H301
|
H301
|
|
GHS08 GHS09 GHS06 Dgr
|
|
|
|
|
1 |
|
View details
|
Repr. 1B |
H360
(dermal,oral)
|
H360
|
STOT RE 2 |
H373
(dermal,oral)
|
H373
|
Aquatic Chronic 1 |
H410
|
H410
|
Acute Tox. 3 |
H301
|
H301
|
|
GHS08 GHS06 Dgr
|
|
|
|
|
1 |
|
View details
|
Repr. 1B |
H360D
|
H360D
|
Number of Aggregated Notifications: 2